8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001193125-24-085437
Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 5.01 Changes in control of the registrant
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d794675d8k.htm…